Precision BioSciences (DTIL) Misses Q4 EPS by 222c

Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($2.22). Revenue for the quarter came in at $640 thousand.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• Nutrien warns shareholders about below-market mini-tender offer